Glutathione and infection

D Morris, M Khurasany, T Nguyen, J Kim… - … et Biophysica Acta (BBA …, 2013 - Elsevier
BACKGROUND: The tripeptide γ-glutamylcysteinylglycine or glutathione (GSH) has
demonstrated protective abilities against the detrimental effects of oxidative stress within the …

NADPH-dependent and-independent disulfide reductase systems

CG Miller, A Holmgren, ESJ Arnér… - Free Radical Biology and …, 2018 - Elsevier
Over the past seven decades, research on autotrophic and heterotrophic model organisms
has defined how the flow of electrons (“reducing power”) from high-energy inorganic …

Low-molecular-mass antioxidants in parasites

RL Krauth-Siegel, AE Leroux - Antioxidants & redox signaling, 2012 - liebertpub.com
Significance: Parasitic infections continue to be a major problem for global human health.
Vaccines are practically not available and chemotherapy is highly unsatisfactory. One …

Thioredoxin glutathione reductase: its role in redox biology and potential as a target for drugs against neglected diseases

S Prast-Nielsen, HH Huang, DL Williams - Biochimica et Biophysica Acta …, 2011 - Elsevier
BACKGROUND: There are two, largely autonomous antioxidant pathways in many
organisms, one based on thioredoxin and one based on glutathione, with each pathway …

Thioredoxin glutathione reductase-dependent redox networks in platyhelminth parasites

DL Williams, M Bonilla, VN Gladyshev… - Antioxidants & redox …, 2013 - liebertpub.com
Significance: Platyhelminth parasites cause chronic infections that are a major cause of
disability, mortality, and economic losses in developing countries. Maintaining redox …

Thioredoxin Glutathione Reductase as a Novel Drug Target: Evidence from Schistosoma japonicum

LJ Song, JH Li, SY Xie, CY Qian, J Wang, W Zhang… - PloS one, 2012 - journals.plos.org
Background Schistosomiasis remains a major public health concern affecting billions of
people around the world. Currently, praziquantel is the only drug of choice for treatment of …

Mapping the catalytic cycle of Schistosoma mansoni thioredoxin glutathione reductase by X-ray crystallography

F Angelucci, D Dimastrogiovanni, G Boumis… - Journal of Biological …, 2010 - ASBMB
Schistosomiasis is the second most widespread human parasitic disease. It is principally
treated with one drug, praziquantel, that is administered to 100 million people each year; …

Current drug targets for helminthic diseases

AK Rana, S Misra-Bhattacharya - Parasitology Research, 2013 - Springer
More than 2 billion people are infected with helminth parasites across the globe. The
burgeoning drug resistance against current anthelmintics in parasitic worms of humans and …

Effects of mammalian thioredoxin reductase inhibitors

ESJ Arnér - Reactive Oxygen Species: Network Pharmacology and …, 2021 - Springer
The mammalian thioredoxin system is driven by NADPH through the activities of isoforms of
the selenoprotein thioredoxin reductase (TXNRD, TrxR), which in turn help to keep …

G6PDH as a key immunometabolic and redox trigger in arthropods

B Moraes, R Martins, C Lopes, R Martins… - Frontiers in …, 2023 - frontiersin.org
The enzyme glucose-6-phosphate dehydrogenase (G6PDH) plays crucial roles in glucose
homeostasis and the pentose phosphate pathway (PPP), being also involved in redox …